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Abstract
Myocardial infarction results in extensive cardiomyocyte death which can lead to fatal arrhythmias or congestive heart
failure. Delivery of stem cells to repopulate damaged cardiac tissue may be an attractive and innovative solution for
repairing the damaged heart. Instructive polymer scaffolds with a wide range of properties have been used extensively to
direct the differentiation of stem cells. In this study, we have optimized the chemical and mechanical properties of an
electrospun polymer mesh for directed differentiation of embryonic stem cells (ESCs) towards a cardiomyogenic lineage. A
combinatorial polymer library was prepared by copolymerizing three distinct subunits at varying molar ratios to tune the
physicochemical properties of the resulting polymer: hydrophilic polyethylene glycol (PEG), hydrophobic poly(e-
caprolactone) (PCL), and negatively-charged, carboxylated PCL (CPCL). Murine ESCs were cultured on electrospun
polymeric scaffolds and their differentiation to cardiomyocytes was assessed through measurements of viability,
intracellular reactive oxygen species (ROS), a-myosin heavy chain expression (a-MHC), and intracellular Ca
2+ signaling
dynamics. Interestingly, ESCs on the most compliant substrate, 4%PEG-86%PCL-10%CPCL, exhibited the highest a-MHC
expression as well as the most mature Ca
2+ signaling dynamics. To investigate the role of scaffold modulus in ESC
differentiation, the scaffold fiber density was reduced by altering the electrospinning parameters. The reduced modulus was
found to enhance a-MHC gene expression, and promote maturation of myocyte Ca
2+ handling. These data indicate that
ESC-derived cardiomyocyte differentiation and maturation can be promoted by tuning the mechanical and chemical
properties of polymer scaffold via copolymerization and electrospinning techniques.
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Introduction
Myocardial infarction (MI) is a leading cause of death in the
United States and throughout the Western world. Following MI,
massive cardiomyocyte death occurs, eventually leading to the
development of arrhythmias and/or congestive heart failure [1].
Myocardium is terminally differentiated tissue with limited
regenerative capacity which cannot compensate for the large scale
loss of cardiac tissue after MI. Currently, heart transplantation is a
viable treatment method for the end stage congestive heart failure,
but is not applicable for early stages of disease progression and is
restricted by the limited number of donors. Cell-based therapies
have therefore emerged as new potential therapeutic options for
treating cardiac diseases [2].
Recently, in situ cellular cardiomyoplasty, a technique in which
cells are delivered directly onto the hypertrophic myocardium, has
shown promise as a potential strategy for myocardial regeneration
following MI. Several types of donor cells have been used for this
purpose, including fetal [3] and adult [4] cardiomyocytes, skeletal
myoblasts [5], bone marrow derived hematopoietic stem cells [6–
8], mesenchymal stem cells [8,9], intrinsic cardiac stem cells
[10,11] and embryonic stem cells (ESCs) [12–18]. ESCs offer
excellent therapeutic potential in terms of the capacity for self-
renewal and the ability to differentiate into cardiomyocytes in vitro,
thereby functionally replacing the diseased cardiac tissue
[13,14,17]. The clinical translation of this approach, however, is
limited by retention, survival and differentiation of ESCs at the
injury site. For example, approximately 90% of cells are lost while
circulating the vasculature or simply leak out of the injection site
[19]. Additionally, the results from preclinical and clinical studies
based on this method have generated inconclusive and mixed
results [5,20–22], indicating that the clinical translation of this
approach is questionable.
An alternative therapeutic strategy to overcome these limita-
tions is cardiac tissue engineering, a process in which cells are
cultured on a natural or synthetic scaffold in vitro before
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introduce the regenerated cardiac tissues at the site of injury
directly attached to the matrix in a patch form. This will give the
cells a foundation to adhere and grow and also minimize any
inflammatory response. The properties of the scaffold can be
manipulated to control cell behavior, including differentiation
towards a specific lineage. The material design criteria for this type
of application include (i) elasticity similar to that of native
myocardium (ii) a biodegradation rate that allows for generation
of new tissues, (iii) biocompatible degradation byproducts, (iv) the
ability to retain and deliver cells and growth factors, (v)
stabilization of cellular interactions with the myocardium, and
(vi) the ability to direct differentiation of cells towards a cardiac
lineage [24,25]. ESC activity can therefore be directed by an
instructive scaffold prior to implantation, thereby improving the
post-operative therapeutic efficacy.
Geron Corporation (Menlo Park, CA) is currently at the
forefront of regenerative medicine using embryonic stem cells for
spinal cord injury [26,27] and also has clinical trials in progress for
cardiovascular remodeling. However, Geron uses proteins such as
bone morphogenetic protein-4 to direct ESC differentiation. We
present here the use of a selective small molecule BMP inhibitor,
DMH1, based on our previous work that chemical inhibition of
BMP is a robust, efficient and scalable means to induce myocardial
differentiation in mouse ES cells [28].
The selection of cells and biomaterial plays an important role in
tissue regeneration [29,30]. Here, we hypothesized that polymeric
biomaterial scaffolds with distinct chemical and mechanical
properties could be employed to enhance the differentiation of
ESCs to cardiomyocytes as a potential patch for cardiac repair.
The various types of synthetic materials composed of poly(ethylene
glycol), poly(lactic acid), poly(glycolic acid) and their copolymer
poly(lactic-co-glycolic acid) have been applied in myocardium
tissue engineering, however, the poor elasticity of these materials
renders them unsuitable for myocardium patches [31]. In this
study, we prepared a library of combinatorial copolymers
containing different mole percentages of three components:
hydrophilic polyethylene glycol (PEG), hydrophobic poly(e-
caprolactone) (PCL), and negatively-charged carboxylated-PCL
(CPCL) to tune the physicochemical, mechanical, and bioactive
scaffold properties for the control of ESC differentiation. Each
polymer subunit was selected for the specific properties it
contributes to the resulting copolymer: PCL is a semi-crystalline,
biodegradable, hydrophobic polymer that has been FDA-
approved in certain devices [32]; PEG is a non-toxic, biocompat-
ible and hydrophilic polymer that reduces protein adsorption and
cell attachment through steric exclusion; and CPCL facilitates cell
attachment to the scaffold surface by providing a negative charge,
effectively counteracting the repellant PEG effect [33]. These
polymers were electrospun to create the extracellular matrix
(ECM)-mimetic fiber structure and their effects on cardiac
differentiation of ESCs were evaluated through a series of in vitro
studies.
In this study, we present the effects of the physicochemical and
mechanical scaffold properties on enhanced cardiac differentiation
of ESCs through analysis of biochemical activities, gene and
protein expression, and physiologically-relevant intracellular
calcium signaling dynamics. Significant progress has been made
recently in terms of developing a proper biomaterial format (e.g.,
injectable hydrogel and, stimuli-responsive scaffolds, and three
dimensional co-culture system) [34–36] as a potential vehicle of
delivering ESCs to dysfunctional myocardium and/or a means of
promoting their cardiac differentiation. Our results provide
important insight into the structure-function relationships that
connect the chemical and mechanical properties of polymeric
biomaterials with physiologically-relevant cardiomyogenic differ-
entiation of ESCs using a combinatorial library of ECM-mimetic
electrospun fiber scaffolds.
Materials and Methods
Chemicals, reagents, and polymers
e-caprolactone and benzyl alcohol were purchased from Alfa
Aesar (Ward Hill, MA, USA). Tin (II) ethyl hexanoate (Sn(Oct)2),
benzyl alcohol, monomethoxypoly(ethylene glycol) (PEG)
(Mn=5000), anhydrous tetrahydrofuran (THF), lithium diisopro-
pylamide (LDA) (2M in THF/n-heptane), anhydrous toluene,
dichloromethane, diethyl ether were purchased from Sigma-
Aldrich Chemicals (St. Louis, MO, USA); and were used as
purchased unless otherwise noted. e-caprolactone was dried and
distilled over CaH2 immediately before polymerization. Tin (II)
ethyl hexanoate was distilled under high vacuum. Benzyl alcohol
was dried and distilled over CaH2.
Copolymers of x mol % PEG, y mol % PCL, and z mol %
CPCL were identified as x%PEG-b-y%PCL-co-z%CPCL where
PEG-PCL is a block copolymer but CPCL addition is random
within the PCL subunit. The polymers are abbreviated x%PEG-
y%PCL-z%CPCL.
Synthesis of poly (e-caprolactone) PCL and
x%PEG-y%PCL diblock copolymers
PCL was synthesized through ring-opening polymerization of e-
caprolactone in bulk using benzyl alcohol and Sn(Oct)2 as the
initiator and catalyst, respectively [37]. Briefly, CL
(100610
23 mol, 11.4 g, 10.96 mL), Sn(Oct)2 (100610
26 mol,
40 mg), and benzyl alcohol (100610
26 mol, 0.10 g, 0.10 ml)
were placed in a previously flame dried, 100 mL round bottom
flask equipped with three-way stopcock connected to manifold and
degassed for 30 min with three freeze-pump-thaw cycles. The
ampoule was immersed in an oil bath at 140uC. After 4 hour
reaction, polymerization was stopped by cooling and the resulting
polymer was dissolved in dichloromethane and precipitated into
excess of diethyl ether. The structure was characterized by
1H
NMR spectra.
1H NMR (CDCl3)=d 4.06 (t, 3H, -OCH2), 2.31(t,
2H, -CH2), 1.66 (m, 2H, -CH2), 1.37 (m, 4H, -CH2) ppm.
The same method was used to synthesize x%PEG-b-y%PCL
diblock copolymers, except with a stoichiometric amount of 5 kDa
monomethoxy-PEG in place of benzyl alcohol as the initiator
(Figure 1). Polymer structure was characterized by
1H NMR
spectra. 4%PEG-96%PCL:
1H NMR (CDCl3)=d 4.06 (t, 3H,
-OCH2), 3.65 (s, 4H, -OCH2), 2.31(t, 2H, -CH2), 1.66 (m, 2H,
-CH2), 1.37 (m, 4H, -CH2) ppm. 8%PEG-92%PCL:
1H NMR
(CDCl3)=d 4.06 (t, 3H, -OCH2), 3.65 (s, 4H, -OCH2), 2.31(t, 2H,
-CH2), 1.66 (m, 2H, -CH2), 1.37 (m, 4H, -CH2) ppm.
Synthesis of 90%PCL-10%CPCL copolymer and
x%PEG-y%PCL-z%CPCL terpolymers
Carboxylated PCL (CPCL) was synthesized as previously
reported [37]. PCL (8.0 g, 0.067 mol) in 400 mL of anhydrous
THF was added under dry nitrogen to a previously flame-dried
round bottom flask. The stirred solution was placed in dry ice/
acetone bath and degassed with three pump-thaw cycles. A
solution of LDA, 2 M in THF/n-heptane (33.5 mL, 0.067 mol: 1
equivalent per monomeric unit), was added drop wise with a
syringe into the reaction, which was then stirred for 30 minutes at
278uC in a bath of dry ice and acetone. A stream of dry CO2 gas
was then generated by addition of concentrated H2SO4 to dry
Na2CO3, and allowed to bubble through the solution for
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to quench the reaction mixture. The resulting solution was
acidified with an aqueous solution of concentrated HCl to pH 2–
3. The resulting copolymer was extracted twice with 100 mL of
dichloromethane. The combined organic phases were washed
twice with 20 mL of distilled water and dried over anhydrous
Na2SO4. After filtration, the solvent was partly evaporated under
reduced pressure and the polymer was precipitated from the
resulting, concentrated solution by addition of diethyl ether. The
90%PCL-10%CPCL copolymer was dried under vacuum for 24 h
and stored at 220uC prior to use.
1H NMR (CDCl3)=d 4.06 (t,
3H, -OCH2), 3.4 (m, 1H, -CH-COOH), 2.31(t, 2H, -CH2), 1.66
(m, 2H, -CH2), 1.37 (m, 2H, -CH2) ppm.
To synthesize x%PEG-b-y%PCL-co-z%CPCL terpolymers, the
same protocol was applied, except using 4%PEG-96%PCL and
8%PEG-92%PCL in place of PCL as starting materials (Figure 1).
4%PEG-86%PCL-10%CPCL:
1H NMR (CDCl3)=d 4.06 (t, 3H,
-OCH2), 3.4 (m, 1H, - CH-COOH), 2.31(t, 2H, -CH2), 1.66 (m,
2H, -CH2), 1.37 (m, 2H, -CH2) ppm. 8%PEG-82%PCL-
10%CPCL:
1H NMR (CDCl3)=d 4.06 (t, 3H, -OCH2), 3.4 (m,
1H, -CH-COOH), 2.31(t, 2H, -CH2), 1.66 (m, 2H, -CH2), 1.37
(m, 2H, -CH2) ppm.
Characterization of polymer synthesis
Gel permeation chromatography (GPC) was performed on a
Tosoh Biosciences TSKGel SuperHZ-M mixed bed column
(4610
6 Da exclusion limit; THF mobile phase) incubated at
40uC, with a Shimadzu SPD-10A UV detector and RID-10A
refractive index detector (Shimadzu Scientific Instruments,
Columbia, MD, USA), and a Wyatt miniDAWN Treos multi-
angle light scattering detector (MALS; Wyatt Technology, Santa
Barbara, CA, USA). Molecular weight (Mn) and polydispersities
(Mw/Mn) were determined against monodisperse poly(methyl
methacrylate) standards (PMMA; Varian Inc., Palo Alto, CA,
USA).
1H NMR spectra were recorded on a Bru ¨ker 400 MHz
spectrometer with CDCl3 as solvent.
Electrospinning and Scanning Electron Microscopy (SEM)
For electrospinning, polymer solutions (10 wt%) in a mixture of
chloroform and methanol (4:1 by volume) was loaded into a plastic
syringe (10 ml) fitted with a stainless steel needle. This needle was
connected to a high-voltage power supply. The solution was
continuously supplied using a syringe pump at a rate of 1 ml/hour
for 10 minutes (e.g. high fiber density meshes). The voltage used
for electrospinning was 18 kV and the collection distance was
10 cm. The resulting fibers were collected over glass cover slips
placed on a rotating mandrel at 1200 rpm. The scaffolds were
dried under vacuum for 24 hours and sterilized by UV irradiation
for 30 minutes before cell culture. This procedure has been proven
to remove toxic organic solvents and sterilize polymer substrates
effectively in previous studies [33,38,39].
To reduce the modulus of electrospun fibers (e.g. low fiber
density meshes), the flow rate of polymer solution was reduced
from 1 to 0.25 ml/hour while keeping the other conditions same.
The fibers were collected over an aluminum woven wire mesh
with a wire diameter of 1.0 mm, a wire spacing of 0.381 mm, and
a dimension of 25 mm (L)610 mm (W) (McMaster-Carr Co.,
Robbinsville NJ, USA).
For SEM imaging, electrospun scaffolds were coated with gold
using a sputter coater (Cressington Scientific, Watford, United
Kingdom) and their fiber structures were examined using SEM
(Hitachi S-4200, Tokyo, Japan) at an accelerating voltage of 5 kV.
Mechanical testing
Dry elastic moduli of electrospun polymer scaffolds were
determined using a tabletop uniaxial testing machine (Bose
ElectroForce 3100, Eden Prairie, MN, USA) using a 10-N load
cell under a cross-head speed of 10 mm/min in ambient
Figure 1. Schematic representation of polymer synthesis PEG-PCL block copolymers were first synthesized by ring-opening
polymerization. CPCL was then randomly added within the PCL subunit. Polymers are abbreviated x%PEG-y%PCL-z%CPCL.
doi:10.1371/journal.pone.0028935.g001
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rectangular form. The thicknesses of test specimens were 0.1 mm
as measured using digital calipers.
Wet elastic moduli of electrospun polymer scaffolds were
measured by dynamic mechanical analysis (DMA, Q800 DMA,
TA Instruments, New Castle, DE, USA) (n=3). Scaffold samples
were prepared in a uniform rectangular form with the dimension
of 15.0 (l)66.6 (w) mm
2. A wet stress and strain curve was obtained
using a submersion clamp containing water at room temperature.
A preload force of 0.1 N was applied to each sample and force was
increased at a rate of 0.1 N/min until failure.
ESC culture
For cell assays, mouse germ line competent CGR8 embryonic
stem cells (European Collection of Cell Cultures, Salisbury, United
Kingdom) were used. To monitor cardiomyogenic differentiation,
CGR8 cells were stably transfected with a construct expressing the
red fluorescent protein gene fused to a nuclear localization signal
(DsRed-Nuc) under the a-myosin heavy chain (a-MHC) promoter.
Therefore, a-MHC-expressing cells are marked with red nuclear
fluorescence, allowing a visual, quantitative assessment of
differentiating cardiomyocytes [40]. CGR8 ESCs were cultured
in GMEM medium with 10% fetal bovine serum (FBS), 100 units/
ml LIF, 2 mM L-glutamine and 50 mM b-mercaptoethanol. ESCs
were grown in differentiation medium (IMDM containing 20%
FBS, 0.1 mM MEM essential amino acids, 2 mM-glutamine and
100 mM b- mercaptoethanol), and maintained in 37uC under 5%
CO2 before use.
Embryoid bodies (EBs) were formed at day 0 by inverting
droplets consisting of 2.5610
4 ESCs/ml in media without LIF in
the presence of Noggin (300 ng/mL) [41] until day 4. Lyophilized
Noggin was purchased from R&D Systems (MN, USA),
reconstituted with 16Phosphate-Buffered Saline (PBS) containing
0.1% BSA as 10 mg/ml stock solutions. To confirm our findings,
cardiomyogenesis was alternatively induced in EBs by adminis-
tration of a selective small molecule inhibitor of BMP type-1
receptor, DMH1 (final concentration, 0.5 mM), during day 0 to 2
of differentiation [28]. Previously, we showed that a small
molecule BMP inhibitor could replace Noggin in the above
mentioned ESC-cardiac induction protocol [28].
After 2 days, the EBs were transferred from hanging drop
culture into Petri dishes. For high fiber density substrates, EBs
were moved at day 4 to electrospun polymer scaffolds coated with
0.2% gelatin on glass cover slips in tissue culture plates. For low
fiber density substrates, fiber meshes were immobilized to the
membrane side of modified transwell insert after removing the
insert membrane. The differences in seeding methods result from
the inability of low density fibers to remain effectively attached to
cover slips; therefore, these meshes were held in place with the
modified transwell insert. At day 10, in vitro measurements were
performed upon visual confirmation of the presence of beating
EBs.
Intracellular Reactive Oxygen Species (ROS) and Cell
Viability
Beating, a-MHC-DsRed-transfected CGR8 cells at day 10 were
used to measure intracellular ROS production and cell viability.
Intracellular hydrogen peroxide production was measured using
dichlorofluorescein diacetate (DCFDA, Invitrogen) following
established methods [38,42]. Cell viability was measured using
calcein AM (Invitrogen). The fluorescence intensity was measured
on a Tecan infinite F500 plate reader (Ma ¨nnedorf, Switzerland)
and normalized to the corresponding cell number measured from
Hoechst nuclear staining.
Gene and protein expression of a-MHC
To measure a-MHC expression, total RNA was extracted from
ESCs using the RNeasy Mini Kit (Qiagen, Valencia, CA)
according to the manufacturer’s instructions and subsequently
treated with RNase-free DNase I (Qiagen). Equal concentrations
of RNA were then reverse-transcribed using the iScript cDNA
synthesis kit (Bio-Rad). Real time-PCR was performed on the Bio-
Rad iCycler iQ (Hercules, CA) using the iQ SYBR Green
Supermix (Bio-Rad) (n=3) and the following primers (all
purchased from Sigma-Aldrich): GAPDH forward 59-CTCACT-
CAAGATTGTCAGCAATG-39 and GAPDH reverse 59-GAGG-
GAGATGCTCAGTGTTGG-39; a-MHC forward 59-TA-
CACTCTTCTCTACCTATGCTTCT-39 and a-MHC reverse
59-CACTATCTTCTTGAACTCAATGC-39. Each primer pair
was tested and its melt curve was analyzed to ensure that only a
single amplicon was generated. Each test sample was assayed for
target gene or GAPDH (reference gene) and the average value was
used as CT. To perform statistical analyses and for graphical
representation, target gene CT values (A) and GAPDH CT values
(B) were both expressed as exponents of 2, and data represented as
the ratio of 2
A/2
B,o r2
(A–B).
To measure a-MHC protein expression, the red fluorescence
intensity of ESCs transfected with the a-MHC-DsRed fusion was
measured through image analysis (n=4). The fluorescence
intensity was normalized to the corresponding cell number
measured from Hoechst nucleus staining.
Intracellular Calcium dynamics
EBs were mechanically detached from their polymer substrates
and re-suspended in 2 ml culture media. EBs were then incubated
for 15 minutes with 5 mM of the cell-permeant Ca
2+ sensitive
fluorophore Fura-2 AM (Invitrogen). EBs were then resuspended
in fresh, dye-free media for 15 minutes to allow for de-
esterification of the acetoxymethyl ester (AM) dye molecule.
In order to record Ca
2+ transients, each EB was field-stimulated
at 1 Hz in a custom built imaging dish using platinum wire
electrodes. Excitation light was multiplexed at wavelengths of
360 nm and 380 nm using a computer controlled monochromator
(Cairn, UK). Resulting fluorescence was recorded at a wavelength
of 510620 nm using an array of optical fibers positioned in the
focal plane of a Zeiss Axiovert 200 microscope (Oberkochen,
Germany) coupled to photomultiplier tubes (Hamamatsu Photon-
ics, Shizuoka, Japan). Recordings were taken at multiple sites on
each EB. Computed fluorescence ratios (I360 nm/I380 nm) were
post-processed with a 200 Hz low-pass filter. The transient
amplitude was defined as the difference between the systolic and
diastolic fluorescence ratios. The decay constant was computed by
fitting a single exponential decay starting from the maximum
fluorescence ratio using Origin (OriginLab, MA, USA).
Immunohistochemistry
At day 11, EBs were fixed with 2% paraformaldehyde and
permeabilized with 0.2% Triton X-100. Cells were blocked with
5% bovine serum albumin in PBS for 30 minutes at 37uC. Cells
were then incubated with Rabbit anti-mouse SERCA2a
(Sarcoplasmic Reticulum Ca
2+ ATPase isoform 2a) IgG antibody
(provided by Dr. Sabine Huke at Vanderbilt University Medical
Center) in 1:1000 dilution with 5% bovine serum albumin in
PBS for 1.5 hours at 37uC, followed by incubation with
secondary FITC-conjugated goat anti-rabbit IgG antibodies
(Sigma-Aldrich). The cells were imaged under a Nikon Eclipse
Ti inverted fluorescence microscope (Nikon Instruments Inc,
Melville, NY).
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In all experiments, results are presented as means 6 standard
error mean (SEM). Comparisons between individual sample
groups were performed using an unpaired Student’s t-test. For
all statistics, p,0.05 was considered statistically significant.
Results
Polymer synthesis and characterization
The test polymers with the general formula x%PEG-y%PCL-
z%CPCL were synthesized (Figure 1) [37,43]. The carboxyl
groups in CPCL were introduced into the PCL chain by anionic
activation of the a-methylene proton by LDA followed by further
reaction with carbon dioxide (CO2) [37]. Characterization of the
resulting polymers by GPC revealed that the Mn ranged from 65–
112.5 kDa, relative to monodisperse PMMA standards (Table 1).
Polymers were electrospun over glass cover slips to form fiber
networks. The diameter, morphology and alignment of fibers were
kept constant by applying similar electrospinning conditions [44].
The average diameter of fibers was found to be 0.5 mm. Table 1
shows dry and wet elastic moduli of electrospun polymer meshes.
The polymers exhibited dry elastic moduli ranging from 7.5861.0
to 23.2166.38 MPa. Among all scaffolds tested, PCL exhibited
the lowest dry elastic modulus (7.5861.0 MPa), whereas the
stiffest material was the 4%PEG-86%PCL-10%CPCL terpolymer
(23.2166.38 MPa). Following hydration to equilibrium, PEG- and
CPCL-containing polymers exhibited a greater decrease in wet
elastic modulus compared to PCL. Because CPCL and PEG
subunits are hydrophilic, segments containing these moieties
became less rigid upon hydration, causing a large decrease in
wet elastic modulus.
Maintenance of ESC Viability on Electrospun Fiber
Scaffolds and Differentiation to Cardiomyocytes
To evaluate ESC viability and their differentiation into cardiomy-
ocytes on fiber scaffolds, EBs [28] were induced to differentiate
towards cardiomyocytes by Noggin treatment and grown on scaffolds
for six days. Upon visual confirmation of contracting cells, cell
viability, intracellular ROS levels, a-MHCexpressionatthegeneand
protein levels, and Ca
2+ ion dynamics were measured.
EBs on all test polymer types showed higher cell viability
compared to control (glass coverslip without polymer, Figure 2a).
In particular, PCL, 4%PEG-96%PCL, 8%PEG-92%PCL and
4%PEG-86%PCL-10%CPCL exhibited the most significant
enhancement in cell viability. Since intracellular ROS have been
implicated in ESC differentiation towards both cardiomyogenic
and vascular cell lineages [45–47], we measured intracellular
hydrogen peroxide (H2O2) and found that test polymer types
differentially regulated intracellular H2O2 production (Figure 2b).
In particular, the terpolymer types (i.e., 4%PEG-86%PCL-
10%CPCL and 8%PEG-82%PCL-10%CPCL) enhanced intra-
cellular H2O2 most significantly.
To further quantify the differentiation of ESCs to cardiomyo-
cytes, gene expression of a-MHC, a marker of the cardiac lineage,
was measured with real time PCR (Figure 2c). EBs on all test
polymer types up-regulated a-MHC gene expression compared to
control. EBs grown on terpolymer fiber scaffolds (i.e., 4%PEG-
86%PCL-10%CPCL and 8%PEG-82%PCL-10%CPCL) exhibit-
ed the greatest increase in a-MHC gene expression (,2-fold
relative to control). To further confirm a-MHC expression,
transfected EBs on fiber scaffolds were imaged and the overall
fluorescence intensity from the a-MHC promoter was quantified
through image analysis (Figure 3). Representative phase contrast
and fluorescence images demonstrate improved attachment of EBs
on 4%PEG-86%PCL-10%CPCL relative to control (Figure 3a).
EBs on the 4%PEG-86%PCL-10%CPCL scaffolds also exhibited
faster beating rates compared to control (data not shown).
Interestingly, the level of a-MHC-related fluorescence in EBs
was dependent on the polymer composition (Figure 3b). EBs
cultured on 4%PEG-96%PCL and 4%PEG-86%PCL-10%CPCL
scaffolds exhibited up-regulated a-MHC expression relative to
control whereas protein expression was substantially down-
regulated in the other test polymer groups.
Taken together, 4%PEG-86%PCL-10%CPCL was found to be
the most favorable polymer composition for maintaining EB
viability and enhancing their differentiation to cardiomyocytes,
whereas 100%PCL was found to be the least favorable
composition for the cellular activities tested.
Effects of Scaffold Mechanical Properties on ESC
Differentiation
Mechanical properties of a polymer substrate can be tuned by
changing electrospinning parameters [44]. Two groups of fiber
scaffolds with different fiber densities were prepared: the first was
prepared by spinning at a flow rate of 1 ml/hour for 10 min, and
the second was prepared by reducing the flow rate (0.25 ml/hour)
and doubling the deposition time (20 minutes) to reduce fiber
density. The orientation could change due to the reduced flow rate
of electrospun polymer solution as the less polymer solution flows
towards the rotting mandrel [44]. However, the results from
assessing the fiber orientation did not show any significance
difference between the low and high fiber density groups (data now
shown). Due to the resulting scaffold morphology by SEM, these
two scaffold types will be referred to as ‘high’ (Figure 4a) and ‘low’
(Figure 4b) fiber density scaffolds, respectively.
Scaffold fiber density proportionally correlated with wet elastic
modulus (Figure 4c). PCL scaffolds with high and low fiber
densities exhibited wet moduli of 0.79 MPa and 0.42 MPa,
respectively. 4%PEG-86%PCL-10%CPCL scaffolds of high and
low fiber densities exhibited lower moduli than PCL (0.71 and
0.28 MPa, respectively). This is likely due to the hydrophilicity of
PEG and CPCL in 4%PEG-86%PCL-10%CPCL which resulted
in increased hydration and water retention relative to hydrophobic
PCL. As a consequence, polymer chains within the terpolymer
scaffolds were better hydrated and separated more freely in an
aqueous environment, leading to lower moduli.
Table 1. Characterization of polymer properties.
Polymer
Mn
a
(Da) PDI
Dry modulus
b
(MPa)
Wet
modulus
c
(MPa)
PCL 91,720 1.25 7.5861.0 0.7960.18
4%PEG-96%PCL 93,070 1.24 21.2963.21 0.8160.01
8%PEG-92%PCL 104,200 1.21 15.4060.77 0.7460.04
90%PCL-10%CPCL 112,800 1.06 13.3362.79 0.9860.04
4%PEG-86%PCL-
10%CPCL
108,400 1.16 18.1162.46 0.7160.04
8%PEG-82%PCL-
10%CPCL
65,350 1.27 23.2166.38 0.8160.02
Mn was measured by GPC according to dn/dc light scattering values. Wet and
dry moduli were calculated from stress/strain measurements.
aMolecular weight measured by GPC in THF,
bMeasured on a uniaxial Bose ElectroForce 3100 mechanical tester,
cMeasured by DMA.
doi:10.1371/journal.pone.0028935.t001
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the gene level, EBs were cultured on two polymers types (PCL and
4%PEG-86%PCL-10%CPCL) at low and high fiber densities and
a-MHC gene expression was measured. Cardiomyogenic differ-
entiation of EBs was shown to be significantly influenced by
scaffold mechanical properties (Figure 4d). For both polymer types
Figure 2. Biochemical activities of EBs on polymer scaffolds. Electrospun polymer scaffolds were shown to enhance cardiac-related
biochemical activities of EBs, compared to control. (a) Cell viability, (b) intracellular H2O2, and (c) a-MHC gene expression. * p,0.05 versus control.
doi:10.1371/journal.pone.0028935.g002
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28935tested, low fiber density scaffolds with decreased moduli promoted
higher a-MHC gene expression than high fiber density scaffolds of
the same material (2-fold higher for PCL, ,3–4-fold higher for
4%PEG-86%PCL-10%CPCL). These results indicate that more
elastic substrates enhance the differentiation of EBs into
cardiomyocytes in the presence of Noggin.
Intracellular Calcium Signaling Dynamics
Ca
2+ handling in cardiomyocytes constitutes a well-defined
sequence of events. Ca
2+ influx into the cells via the voltage gated
L-type Ca
2+ channel provides a trigger to release an increased
amount of Ca
2+ from the sarcoplasmic reticulum (SR) Ca
2+ store
through Ca
2+-sensitive ryanodine receptors (RyRs). The Ca
2+
binds to troponins and initiates contraction before it is taken up by
the SR Ca
2+ ATPase (SERCA) or transported across the
sarcolemma membrane by the sodium calcium exchanger
(NCX) [48]. To further validate the ability of fiber mesh scaffolds
to enhance the differentiation of EBs into cardiomyocytes,
intracellular Ca
2+ transients were recorded from isolated EBs
from scaffolds of differing compositions and densities. Because low
density fiber scaffolds were shown to enhance a-MHC expression
more effectively than high fiber density scaffolds, we compared
PCL versus 4%PEG-86%PCL-10%CPCL in a low density format
and PCL versus glass in a high density format (Figure 5). Due to
potential different dye loading conditions of low and high density
fiber samples, differences in calcium dynamics between the two
types of samples were not directly compared.
The ratio of the fluorescence emission intensities of the Fura-2
fluorophore recorded from EBs at 360 and 380 nm correlates
directly to the absolute intracellular Ca
2+ concentration. By
recording Fura-2 fluorescence ratios during a train of 1 Hz field
stimulation, the calcium transients corresponding to individual
contractions were obtained.
EBs from high fiber density 4%PEG-86%PCL-10%CPCL
scaffolds were compared to control (EBs cultured on glass without
polymers, Figure 5a–c). Because low fiber density scaffolds were
shown to enhance a-MHC expression relative to high density
scaffolds, the two polymer types were compared in a low fiber
density format. For measurements of the intracellular calcium
dynamics (Figure 5d–f), the ratio of the fluorescence intensities of
the Fura-2 fluorophore were correlated to intracellular Ca
2+. High
fiber density 4%PEG-86%PCL-10%CPCL meshes resulted in a
larger Ca
2+ transient amplitude when compared to control (glass
only, Figure 5a, b), and low fiber density 4%PEG-86%PCL-
10%CPCL meshes promoted a larger Ca
2+ transient amplitude
(Figure 5 d, e) and a faster decay time t, indicative of SERCA
activity, when compared to PCL (Figure 5f). Regardless of polymer
composition, low fiber density substrates enhanced Ca
2+ transient
amplitude more effectively than high fiber density 4%PEG-
86%PCL-10%CPCL, indicating the strong influence of fiber
density and mechanical properties on cardiomyogenic differenti-
ation in the presence of Noggin.
For both low and high fiber density substrates, 4%PEG-
96%PCL-10%CPCL fiber meshes promoted enhanced Ca
2+
cycling, which indicates that EBs cultured on this polymer result
in more ESC-derived cardiomyocytes compared to PCL only or
glass control. These data suggest that the EBs isolated from the
terpolymer scaffolds possess a propensity for improved Ca
2+
handling, indicating superior cardiac function.
DMH1 Treatment and SERCA2 expression
We previously showed that dorsomorphin, a small molecule
inhibitor of BMP type-I receptor promotes differentiation of
murine ESCs into cardiomyocytes by at least 20-fold, at the
expense of other mesodermal tissues [28]. Here, we used a more
selective BMP inhibitor DMH1 to promote cardiomyogenesis in
ES cell. When EBs were differentiated without DMH1, there was
minimal induction of cardiomyogenesis [28]. Correspondingly,
when ES cells were differentiated in the absence of DMH1 and
were stained for SERCA2, there was minimal expression
(Figure 6). Thus, although it is possible that increased SECRA2
expression following DMH1 treatment is partially from non-
cardiac sources, our results suggest strongly that increased
SERCA2 expression originates from cardiomyocytes induced by
DMH1 treatment. Since efficient calcium sequestration into the
sarcoplasmic reticulum by SERCA2 is a feature of functional
cardiomyocyte (Figure 5f), our data suggests that little or no
functional cardiomyocytes form during traditional EB differenti-
ation protocol, although low SERCA2 expression was observed on
4%PEG-86%PCL-10%CPCL (Figure 6). By contrast, EBs in-
Figure 3. EB attachment and protein expression. (a) Phase
contrast and fluorescence images of EBs are shown at day 10. Cells were
cultured on gelatin coated glass cover slips with and without 4%PEG-
86%PCL-10%CPCL copolymer scaffolds. Cells grown on 4%PEG-
86%PCL-10%CPCL maintained more adhered, circular EBs and (b)
exhibited higher a-MHC protein expression. Scale bars=10 mm.
* p,0.0005 versus control.
doi:10.1371/journal.pone.0028935.g003
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substantial SERCA2 expression even without polymers (Figure 6).
Importantly, while there was no increase in SERCA2 expression
on PCL, DMH1- treated EBs grown on low fiber density 4%PEG-
86%PCL-10%CPCL showed markedly increased SERCA2 ex-
pression (Figure 6). These results further support low fiber density
4%PEG-86%PCL-10%CPCL as the preferred substrate for
enhanced differentiation of ESCs to mature cardiomyocytes with
functional excitation contraction coupling.
Discussion
ESCs are promising therapeutic candidates in regenerative
medicine due to their pluripotency and capacity for self-renewal.
In recent years, much progress has been made to understand the
microenvironmental cues that control the differentiation of ESCs
towards particular lineages [45–48]. Precise guidance of ESC
behavior is mandatory for clinical translation of ESC-based
therapies to become a reality. Insights into structure-function
relationships between the microenvironment and ESCs assist in
the design of synthetic scaffolds that more effectively control ESC
differentiation. For example, polymeric biomaterials can be
designed to mimic a 3D extracellular matrix (ECM) network that
facilitates the maintenance of cell homeostasis, phenotype, and
behavior [49]. The recapitulation of such cues and signals in a 3D
polymer structure is possible by tuning the desired chemical and
mechanical properties through copolymerization techniques. The
results presented here indicate that polymer scaffold composition
and mechanical properties both play central roles in EB formation,
development and their subsequent differentiation into cardiomy-
ocytes.
To investigate the influence of scaffold properties on ESC
behavior, a library of polymers (x%PEG-y%PCL-z%CPCL) was
synthesized, characterized, and prepared as fiber substrates by
electrospinning to mimic the ECM network. Each polymeric
component was selected for the specific contributions made to the
chemical and mechanical properties of the resulting copolymer:
PCL is a semi-crystalline, hydrophobic polymer that exhibits slow
degradation kinetics with biocompatible byproducts; PEG is a
hydrophilic polymer that absorbs water and repels nonspecific
protein adsorption through steric exclusion [33]; CPCL further
promotes water absorption and facilitates cell attachment by
providing a negative charge at the surface. Therefore, the presence
of CPCL is expected to buffer the repellent character of PEG while
simultaneously increasing hydrophilicity of the resulting material
[33]. PCL was selected as the primary component of all polymer
types tested because we have previously demonstrated it to be ideal
for cardiovascular applications [50,51].
The physical properties of these scaffolds were first evaluated for
their applicability for cardiac regeneration. The modulus of native
rat myocardium ranges from about 10 to 150 kPa [31,52,53]. The
differentiation of cardiomyocytes from cardiac stem cells on a
square grid poly L-(lactic acid) scaffold with a Young’s modulus of
about 300 kPa was successfully demonstrated [54]. Because the
wet moduli of all scaffolds fell within the same order of magnitude,
the electrospun test polymers were predicted to be ideal for this
Figure 4. Effect of mechanical properties on EB differentiation. (a) SEM images of (a) high fiber density and (b) low fiber density scaffolds. (c)
Wet modulus of PCL and 4%PEG-86%PCL-10%CPCL. * p,0.05 versus high density fibers. (d) a-MHC gene expression is enhanced on low versus high
density fiber scaffolds, indicating improved differentiation. * p,0.05 versus high density PCL **p,0.0005 versus high density 4%PEG-86%PCL-
10%CPCL.
doi:10.1371/journal.pone.0028935.g004
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evaluate enhancement of ESC cardiomyogenic differentiation on
polymer substrates. Eventually, 4%PEG-86%PCL-10%CPCL was
selected as an ideal chemical composition among the test
polymers. Moreover, the wet modulus of 4%PEG-86%PCL-
10%CPCL low density fibers showed a modulus around 280 kPa,
which is similar to myocardium modulus, and our results
demonstrated the promoted differentiation of cardiomyocytes
from mouse ESCs on this type of fibers.
Copolymerization techniques enabled us to evaluate the effects
of scaffold composition and the resulting mechanical properties on
ESC differentiation. Compared to EBs grown on control glass
slides, EBs grown on all test scaffolds exhibited enhanced
adherence and viability, elevated intracellular H2O2 production,
and increased a-MHC expression at the gene and protein levels—
all of which indicate differentiation towards a cardiomyogenic
lineage [45–47]. The slight elevation in intracellular H2O2 in EBs
cultured on 4%PEG-86%PCL-10%CPCL represents healthy
redox signaling that promotes differentiation without excessive,
pathogenic overproduction of ROS [47]. While other polymers
also caused an increase in intracellular H2O2 without a loss of cell
viability (Figures 2), only the 4%PEG-86%PCL-10%CPCL
terpolymer was able to promote a concurrent up-regulation of
a-MHC gene and protein expression. Based on these data, we
selected this particular polymer composition as the optimal
formulation for enhancing EB differentiation for the remainder
of the studies. In contrast, PCL fiber meshes demonstrated the
weakest ability (closest to control) to enhance intracellular H2O2
production and a-MHC expression relative to other test polymer
types; therefore, PCL was selected as the most suitable polymer
control for the remainder of experiments.
Because substrate elasticity has been shown to tightly regulate
stem cell differentiation, we evaluated the effects of scaffold
mechanical properties on cardiomyogenic differentiation [55,56].
Figure 5. Polymer substrate elasticity affects Ca
2+ dynamics of EBs. Ca
2+ transients were recorded from isolated EBs from polymer scaffolds
using the fluorescent ratiometric calcium dye Fura-2. EBs were subjected to 1 Hz field-stimulations during recordings. (a, d) Representative
fluorescence traces showing the calcium transient accompanying a electrically stimulated single contraction. (b, e)C a
2+ transient amplitude,
measured as the difference between diastolic and systolic Ca fluorescence intensities. (c, f) Decay constant of the Ca
2+ transient, calculated by fitting
the decay to a single exponential decay function. *p,0.05 and ** p,0.0005.
doi:10.1371/journal.pone.0028935.g005
Combinatorial Polymers and ESC Differentiation
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e28935To tune the scaffold mechanical properties, fiber scaffolds were
deposited at high and low fiber densities by altering electrospin-
ning parameters. The diameter, morphology and alignment of
both fiber scaffold types were kept constant by applying similar
electrospinning conditions. Compared to high fiber density
scaffolds, EBs cultured on low fiber density 4%PEG-86%PCL-
10%CPCL scaffolds exhibited enhanced a-MHC gene expression,
indicating that a compliant substrate of the same chemical
composition more effectively enhances cardiac differentiation in
the presence of Noggin. We then hypothesized that this same
scaffold would promote the most functional ESC-derived cardio-
myocytes that exhibit calcium signaling dynamics that are
characteristic of ventricular excitation contraction coupling.
Indeed, this was verified by measurements of Ca
2+ transients
which revealed a physiological time course for the de- and re-
polarization and functional cardiac excitation contraction cou-
pling.
These findings were further supported by monitoring the
expression of SERCA2a, a protein involved in Ca
2+ transport. In
the absence of DMH1, an inhibitor of the BMP signaling pathway,
only EBs cultured on low fiber density 4%PEG-86%PCL-
10%CPCL scaffolds exhibited a recognizable level of SERCA2a
expression (Figure 6). Upon treatment with DMH1, EBs on all
substrates expressed SERCA2a, but those cultured on 4%PEG-
86%PCL-10%CPCL demonstrated the most significant up-
regulation (Figure 6). These data indicate that low fiber density
4%PEG-86%PCL-10%CPCL scaffolds optimally enhanced the
physiologically-relevant cardiomyogenic differentiation of ESCs.
Matrix stiffness directs stem cell differentiation into particular
lineages on substrates with elasticity similar to respective native
tissue [56]. In our study, the wet modulus of 4%PEG-86%PCL-
90%CPCL low density fibers was about 280 kPa, which was
relatively close to the modulus of the native myocardium
[31,52,53] and induced the highest cardiomyocyte differentiation
compared to stiffer substrates (Figure 3,4 and 6). Stem cells sense
the rigidity of substrate and are expected to have elevated levels of
phosphorylated focal-adhesion kinases when cultured on stiffer
scaffolds [56,57], which in turn promote the proliferation or
migration of stem cells and inhibit the cardiomyocyte differenti-
ation [58]. Moreover, the introduction of high porosity by low
density fibers not only decreased the elasticity, but also contributed
more accessible surface area to cells [59]. Thus the 4%PEG-PCL-
CPCL low density fibers led to enhanced cardiogenesis as a result
of combined low elasticity and high porosity.
Our findings demonstrate that the augmented differentiation of
ESCs into healthy and electrophysiologically-functional cardio-
myocytes relies heavily upon scaffold composition and mechanical
properties. Through scaffold preparation by electrospinning, we
have identified low fiber density 4%PEG-86%PCL-10%CPCL as
the best substrate for enhanced cardiomyogenic differentiation of
ESCs in the presence of the BMP inhibitor Noggin or DMH1. We
have deduced that a more compliant substrate effectively promotes
EB adhesion and cardiomyogenic differentiation, as verified by
changes in gene and protein expression, biochemical activities, and
Ca
2+ signaling dynamics.
This approach for cardiac tissue engineering further supports
the development of material-based guidance of ESC differentia-
tion through elucidation of cell-matrix interactions. Our findings
provide additional insight into the development of instructive
matrices for enhanced post-operative differentiation, an under-
standing that is essential for the clinical translation of ESCs for
cardiac repair. The advantages of our approach include scalability,
reproducibility, low cost, and simplicity of fabrication. Addition-
ally, the electrophysiological behavior of differentiated cardiomy-
ocytes using this approach was similar to those described by others
using alternative methods, thereby further supporting the utility of
this approach as a feasible, clinically-relevant method for directed
ESC differentiation.
Conclusions
The present study describes the synthesis and characterization
of electrospun fibers comprised of a subset of a library of polymers
with different physicochemical properties. Among the polymers
tested, the polymer composition of 4%PEG-86%PCL-10%CPCL
optimally facilitated the differentiation of ESCs into functional
cardiomyocytes. This effect correlated with the local density of
deposited fibers, demonstrating a relationship between substrate
mechanical properties and cell differentiation. The resulting
cardiomyocytes were electrophysiologically functional, possessing
desired Ca
2+ depolarization and repolarization pathways. These
results are promising for the treatment of cardiac ischemia, where
the ensuing myocardial hypoxia, necrosis, and fibrosis may be
treated through the delivery of a tissue-engineered myocardial
patch. The methods described provide an efficient way to induce
functional cardiomyocytes from pure ESCs, which is of great
interest to the areas of regenerative medicine biomaterials, tissue
engineering, cardiology, and stem cell biology.
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